A Clinical Trial of a Hemp-Derived Cannabidiol Product for Anxiety
- Conditions
- Anxiety
- Registration Number
- NCT04286594
- Lead Sponsor
- Mclean Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Terminated
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria:<br><br> - Subject has provided informed consent<br><br> - Subject is 18 or older<br><br> - Subject is a native English speaker or acquired English prior to age 5<br><br> - Subject endorses moderate or severe anxiety at the screening visit<br><br>Exclusion Criteria:<br><br> - Non-native English speakers<br><br> - Estimated IQ < 75<br><br> - Current substance abuse/dependence, psychotic disorder, bipolar disorder, or an<br> eating disorder<br><br> - A history of head injury or loss of consciousness greater than 5 minutes<br><br> - Currently uses marijuana or cannabinoid-based products more frequently than 1x/month<br><br> - Female subjects will be excluded if they have a positive urine pregnancy test, or if<br> they are currently breastfeeding<br><br> - Presence of a serious medical illness, including liver or kidney disease, or<br> neurological disorder<br><br> - Allergy to coconut oil<br><br> - Current use of valproate<br><br> - Additional exclusions related to MR imaging, including claustrophobia, metal<br> implanted within the body, etc.
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Self-Reported Anxiety as Assessed by the Beck Anxiety Inventory (BAI)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.